Indicated for: cancer
Route of administration: oral
Substance: vinorelbine (antineoplastic agent)
ATC: L01CA04 (Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Vinca alkaloids and analogues)
Vinorelbine is a chemotherapy medication used for the treatment of various types of cancer, including non-small cell lung cancer and advanced breast cancer. It belongs to the vinca alkaloid class and works by inhibiting tubulin polymerization, which leads to the arrest of cell division and ultimately tumor cell death.
Vinorelbine is administered intravenously or orally, depending on the type and stage of cancer, and the dosage is adjusted based on body weight and patient response. Treatment is usually given in cycles to allow the body to recover between doses.
Common side effects include nausea, vomiting, fatigue, alopecia, and myelosuppression (reduction in blood cell counts). In rare cases, severe adverse reactions such as peripheral neuropathy or liver function impairment may occur.
Patients receiving vinorelbine should be regularly monitored for hematologic function and signs of toxicity. The medication is an important option in cancer treatment, helping to reduce tumor size and prolong patient survival.